期刊文献+

血液灌流联合血液透析对慢性肾脏病矿物质与骨异常患者血磷免疫反应性甲状腺激素水平的影响 被引量:17

下载PDF
导出
摘要 慢性肾脏病是对人类生命安全危害极强的疾病,具有发病率高、致死率高等特点,据流行病学研究结果显示,全球范围内慢性肾脏病患病率高达10%,随着现代医学技术的不断提升,医用设备的不断更新完善,针对慢性肾脏病终末期的治疗已经获得极大突破。慢性肾脏病矿物质及骨异常是该病主要并发症,对患者生存质量有着严重影响,慢性肾脏病患者因肾功能衰减,机体将出现各种骨代谢异常及矿物质异常,从而引发血管钙化、肾性骨病、继发性甲状旁腺功能亢进等疾病,严重降低患者生活质量,死亡风险大大增加。
作者 陈亚然
出处 《山西医药杂志》 CAS 2018年第15期1820-1822,共3页 Shanxi Medical Journal
  • 相关文献

参考文献7

二级参考文献50

  • 1姜鸿,徐志宏,张凌,宋韩明,李文歌.慢性肾脏病3~5期透析前患者矿物质及骨代谢紊乱的调查分析[J].中国血液净化,2012,11(7):360-364. 被引量:43
  • 2郭凤琴,张春丽,王荣福,冯惠梅,王梅.肾性骨营养不良患者骨组织形态学变化与血生化指标的关系[J].中国临床康复,2005,9(7):100-101. 被引量:6
  • 3Sobaszek-Pitas M, Krzanowska K, Su P wicz W. Comparison of the iron metabolism and effectiveness of anemia treatment in patients on- maintenance hemodialysis performed based on polysulfone and he- lixone dialyzers[J]. Przegl Lvk, 2014, 71(8): 418-422.
  • 4Gong L, Lin J, Yah J, et al. Effect of puncture-related pain on the qual- ity of life in patients undc/goingmaintenance hcmodialysis through internal arteriovenous fistula [J]. Journal of Central South University (Medical Sciences), 2014, 39(12): 1292-1298.
  • 5Satirapoj B, Supasyndh 0, Choovichian P. A comparative study of ef- ficacy and safety of the lyophilized powder alpha-crythropoietin and the liquid form alpha-erythropoietin for hemoglobin maintenance in patients withhemodialysis treatment [J]. J Med Assoc Thai, 2014, 97 (9): 899-906.
  • 6Duman N, Uyanik A, Unsal A, et al. Once-monthly continuous cry- thropoietin receptor activator (CERA) for haemoglobinmaintenance in haemodialysis patients with chronic renal anaemia[J]. Clin Kidney J, 2014, 7(5): 464-469.
  • 7Toida T, Sato Y, Shibata N, et ai. A Randomized Control Study on the Procedure for Switching Epoetin Beta (EPO) to Epoetin Beta Pegol (CERA) in the Treatment of Renal Anemia in Maintenance HemodialysisPatients[J]. Blood Purif, 2014, 38(3-4): 174-179.
  • 8Zhang P, Yang LN, Wang G, et al. Serum hepcidin level and its clini- cal significance in maintenance hemodialysispatients [J]. CJenet Mol Res, 2014, 13(4): 9883-9888.
  • 9Dbska-liziefi A, Malgorzewicz S, Dudziak M, et al. Cardiovascular risk in patients undergoing maintenance hemodiaiysis with Helixone membrane: a multicenter randomized study[J]. Pol Arch Med Wewn, 2014, 124(11): 593-598.
  • 10Tsai MH, Fang YW, Leu JG. Tinzaparin provides lower lipid profiles in maintenance hemodiaiysis patients: a cross-sectional observational study[J]. Scientific World Journal, 2014, 2014:486781.

共引文献80

同被引文献136

引证文献17

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部